NCT02528006View on ClinicalTrials.gov

Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 27, 2015

Primary Completion Date

March 29, 2017

Study Completion Date

March 29, 2017

Conditions
Adductor Spasmodic Dysphonia
Interventions
DEVICE

Type 2 Thyroplasty using Titanium Bridges

Trial Locations (4)

060-8638

Hokkaido University Hospital, Sapporo

236-0027

Yokohama City University, Yokohama

860-8556

Kumamoto University Hospital, Kumamoto

606-8501

Kyoto University Hospital, Kyoto

All Listed Sponsors
collaborator

Hokkaido University Hospital

OTHER

collaborator

Yokohama City University Hospital

UNKNOWN

collaborator

Kyoto University

OTHER

lead

Kumamoto University

OTHER

NCT02528006 - Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges | Biotech Hunter | Biotech Hunter